Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma
Open Access
- 29 July 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 17 (8) , 1650-1657
- https://doi.org/10.1038/sj.leu.2403026
Abstract
Chromosomal band 1p34–36 is a commonly rearranged locus in many types of cancers. We cloned the breakpoint region of a chromosomal translocation, t(1;14)(p34;q32), found in the human multiple myeloma (MM) cell line, ODA. This rearrangement occurred between the nearby switch region of the immunoglobulin heavy chain (IgH) gene (Sγ3) at 14q32 and the first intron of the human retinoic acid-inducible E3 protein (E3)/lysosome-associated protein, transmembrane-5 (LAPTm5) gene at the 1p34 locus. Consequently, the E3 gene, which is a hematopoietic cell-specific transcript induced by retinoic acid and located at the rearranged allele, was interrupted within its coding region and was not expressed in the ODA cell line in spite of the other allele still being intact. The expression derived from the remaining intact allele in ODA cells was silenced by DNA methylation at sequences within the first intron around a GC-rich EagI site. Interestingly, the silenced expression of E3 mRNA due to DNA methylation of intron 1 sequences was frequently encountered in MM cells [6/10 (60%) of MM cell lines tested], while E3 is expressed in normal plasma cells and in most other hematopoietic cell lines including those of B-cell lineage. Thus, as the E3 protein has been suggested to be involved in cellular differentiation and apoptotic pathways in certain cell types, our results suggest that loss of E3 gene expression might be a crucial event during the progression of human MM.Keywords
This publication has 21 references indexed in Scilit:
- 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemiaBlood, 2002
- Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumorsBlood, 2001
- Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome paintingCancer Genetics and Cytogenetics, 2001
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal TranslocationsJapanese Journal of Cancer Research, 2001
- Activation of a novel microglial gene encoding a lysosomal membrane protein in response to neuronal apoptosisMolecular Brain Research, 2001
- Leiomyosarcomas and Most Malignant Fibrous Histiocytomas Share Very Similar Comparative Genomic Hybridization Imbalances: An Analysis of a Series of 27 LeiomyosarcomasLaboratory Investigation, 2001
- Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaNature Genetics, 1997
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- LAPTM5: A Novel Lysosomal-Associated Multispanning Membrane Protein Preferentially Expressed in Hematopoietic CellsGenomics, 1996
- Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non‐Hodgkin's lymphomas with BCL6/LAZ3 rearrangementGenes, Chromosomes and Cancer, 1995